Literature DB >> 15490481

An oxidative stress mechanism mediates chelerythrine-induced heparin-binding EGF-like growth factor ectodomain shedding.

Jayoung Kim1, Jianqing Lin, Rosalyn M Adam, Carolyn Lamb, Sharon Baughman Shively, Michael R Freeman.   

Abstract

Regulated shedding of cell surface proteins is a mechanism for rapid activation of autocrine and paracrine signaling. Here we report that chelerythrine, a protein kinase C (PKC) inhibitor that possesses a variety of biological functions, is a potent inducer of heparin-binding epidermal growth factor-like growth factor (HB-EGF) shedding from the cell surface. Chelerythrine induced a time- and dose-dependent shedding of an HB-EGF-alkaline phosphatase (HB-EGF-AP) fusion protein expressed in MC2 rat prostate epithelial cells. The soluble form of HB-EGF-AP bound to heparin and exhibited potent biological activity as measured by DNA synthesis assay. Chelerythrine-induced HB-EGF shedding was metalloproteinase-(MMP-) mediated because specific MMP antagonists inhibited shedding by > or =60%. Chelerythrine stimulated production of reactive oxygen species, and antioxidants prevented chelerythrine-induced HB-EGF shedding, suggesting that the production of intracellular peroxides is necessary for this event. Consistent with this possibility, antioxidant- and MMP-inhibitable shedding was also demonstrated when hydrogen peroxide was used as an inducer. Although JNK/SAPK and p38 MAPK pathways were activated by chelerythine, these signaling mechanisms were not required to mediate the shedding event. However, JNK signaling was involved in chelerythrine-stimulated apoptosis. Our results suggest that HB-EGF shedding induced by chelerythrine is mediated predominantly via the production of reactive oxygen species. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15490481     DOI: 10.1002/jcb.20276

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  Interaction of the putative anticancer alkaloid chelerythrine with nucleic acids: biophysical perspectives.

Authors:  Anirban Basu; Gopinatha Suresh Kumar
Journal:  Biophys Rev       Date:  2020-10-31

2.  Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.

Authors:  D Randall Armant; Brian A Kilburn; Anelia Petkova; Samuel S Edwin; Zophia M Duniec-Dmuchowski; Holly J Edwards; Roberto Romero; Richard E Leach
Journal:  Development       Date:  2006-01-11       Impact factor: 6.868

3.  Identification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1.

Authors:  Annelize Z B Aragão; Maria Luiza C Nogueira; Daniela C Granato; Fernando M Simabuco; Rodrigo V Honorato; Zaira Hoffman; Sami Yokoo; Francisco R M Laurindo; Fabio M Squina; Ana Carolina M Zeri; Paulo S L Oliveira; Nicholas E Sherman; Adriana F Paes Leme
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

Review 4.  Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.

Authors:  Ling Zhang; Rolf Postina; Yingqun Wang
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

5.  Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor.

Authors:  Richard E Leach; Brian A Kilburn; Anelia Petkova; Roberto Romero; D Randall Armant
Journal:  Am J Obstet Gynecol       Date:  2008-04       Impact factor: 8.661

6.  Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway.

Authors:  Mohammed E Abo-El Fetoh; Gouda K Helal; I G Saleh; M Ewees; Mohamed ElShafey; Mohamed R Elnagar; El-Sayed Akool
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-01-06       Impact factor: 3.000

7.  Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction.

Authors:  Alejandro F Prado; Laena Pernomian; Aline Azevedo; Rute A P Costa; Elen Rizzi; Junia Ramos; Adriana F Paes Leme; Lusiane M Bendhack; Jose E Tanus-Santos; Raquel F Gerlach
Journal:  Redox Biol       Date:  2018-07-09       Impact factor: 11.799

8.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30

9.  Structure-activity relationship of benzophenanthridine alkaloids from Zanthoxylum rhoifolium having antimicrobial activity.

Authors:  Luciana de C Tavares; Graciane Zanon; Andréia D Weber; Alexandre T Neto; Clarice P Mostardeiro; Ivana B M Da Cruz; Raul M Oliveira; Vinicius Ilha; Ionara I Dalcol; Ademir F Morel
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development.

Authors:  Navasona Krishnan; Christopher A Bonham; Ioana A Rus; Om Kumar Shrestha; Carla M Gauss; Aftabul Haque; Ante Tocilj; Leemor Joshua-Tor; Nicholas K Tonks
Journal:  Nat Commun       Date:  2018-01-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.